Paul Mattheis
Analyst
Stifel
Equibles does not estimate personal net worth.
About Paul Mattheis
Paul Mattheis is recorded as Analyst at Stifel. Paul Mattheis has spoken on 1 earnings call across 1 company, most recently for Rhythm Pharmaceuticals, Inc. on August 4, 2026. The companies whose calls Paul Mattheis spoke on are classified in the Healthcare sector.
Paul Mattheis on recent calls
“And I was wondering if you could comment on what you're seeing as it relates to either concomitant use with GLP-1s or whether there's physicians or many physicians are kind of looking to try a GLP-1 before in Sivri.”
Affiliation history
-
Stifel
Analyst
Transcript header (unverified)
Current